Drugmaker Mylan
Biocon Gets A Shot In The Arm With FDA Approval For Insulin Glargine
Banking - Published date: .
The drug will be major contributor in the firm's bid to reach $1 billion revenue target by FY22, says biologics CEO Hama... Read more